drugset / Trial / NCT02152332
A Study to Evaluate the Effects of JNJ-54861911 on Electrocardiogram Intervals in Healthy Particiants
RandomizedCrossoverDouble-blindTreatment
Summary
The purpose of this study is to evaluate the effects of JNJ-54861911 on the QT/QTc intervals in healthy participants, when administered at therapeutic (50 milligram \[mg\] once-daily) and supratherapeutic (150 mg once-daily) doses for 7 days.
Timeline
- Start
- 2014-07
- Primary completion
- 2014-10
- Completion
- 2014-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atabecestat | Small molecule | 50 mg | — |
| Subject | Atabecestat | Small molecule | 150 mg | — |
| Subject | Moxifloxacin | Small molecule | 400 mg | — |
Indications
No indication recorded.